Carlyle Group’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Carlyle Group’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-192,884	Closed	-$55.9K	–	33
2024 Q2	$55.9K	Hold	192,884	–	–	0.01%	30
2024 Q1	$2.72M	Sell	192,884 -1	-0%	-$12	0.17%	19
2023 Q4	$2.23M	Hold	192,885	–	–	0.11%	20
2023 Q3	$2.87M	Hold	192,885	–	–	0.12%	21
2023 Q2	$3.95M	Hold	192,885	–	–	0.14%	20
2023 Q1	$1.69M	Buy	+192,885	New	+$2.34M	0.05%	24

Other funds holding EFTR

Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return

Blackstone Inc New York $24.2B AUM 26.83% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return